PartnerRe Asset Management’s Edwards Lifesciences EW Stock Holding History

PartnerRe Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,326	Closed	-$127K	–	140
2016 Q1	$127K	Hold	4,326	–	–	0.06%	236
2015 Q4	$114K	Sell	4,326 -7,350	-63%	-$191K	0.06%	254
2015 Q3	$277K	Buy	11,676 +18	+0.2%	+$434	0.05%	279
2015 Q2	$277K	Sell	11,658 -2,010	-15%	-$45.4K	0.05%	295
2015 Q1	$325K	Hold	13,668	–	–	0.05%	294
2014 Q4	$290K	Buy	13,668 +2,016	+17%	+$40.5K	0.05%	323
2014 Q3	$198K	Sell	11,652 -1,806	-13%	-$28.5K	0.04%	360
2014 Q2	$193K	Sell	13,458 -2,094	-13%	-$28.4K	0.03%	406
2014 Q1	$192K	Sell	15,552 -252	-2%	-$2.91K	0.03%	427
2013 Q4	$173K	Sell	15,804 -1,362	-8%	-$15.4K	0.03%	438
2013 Q3	$199K	Sell	17,166 -2,388	-12%	-$27.9K	0.03%	411
2013 Q2	$219K	Buy	+19,554	New	+$231K	0.04%	395

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

PartnerRe Asset Management's EW Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Edwards Lifesciences (EW) in Q2 2016, closing a stake of 4,326 shares — an estimated $127K sold.

PartnerRe Asset Management first reported a position in EW in Q2 2013 and held it in 12 quarters. The position peaked at $325K in Q1 2015. 693 funds tracked by Wall St. Rank hold EW as of Q2 2016.

PartnerRe Asset Management reported no remaining Edwards Lifesciences position as of Q2 2016 after selling out during the quarter.
PartnerRe Asset Management sold 4,326 Edwards Lifesciences shares in Q2 2016, an estimated $127K.
PartnerRe Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 12 quarters.
PartnerRe Asset Management's Edwards Lifesciences position peaked at $325K in Q1 2015.
693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.